HANDLING CONFLICT OF INTEREST (COI)

Track:
Involvement of Patients and Academia as Experts in the Drug Approval Process

Day & Time:
March 5, 4:00PM - 5:30PM

Session Number:
0904

Room Number:
G105

Type:
Session

Title:
HANDLING CONFLICT OF INTEREST (COI)

Chair(s):
Noel Wathion, RPh
Head of Patient Health Protection
European Medicines Agency, European Union, United Kingdom

Description:
Patients and experts are increasingly involved in drug regulatory assessment. Transparency in the management of potential conflict of interest is of paramount importance. The session also elaborates on finding the right balance between minimising conflicts of interests versus the availability of the best possible expertise.

Presentation(s) & Speaker(s):
EMA Handling of Conflicts of Interests: Current status and how to move forward
Noel Wathion, RPh
Head of Patient Health Protection
European Medicines Agency, European Union, United Kingdom

Searching for the Perfect Expert: Regulatory and academic experience
Gonzalo Calvo Rojas, PhD
Clinical Pharmacologist
Hospital Clinic Barcelona, Spain

Interaction between Industry and Academia: Impact of conflicts of interest
Ruth Diazaraque-Marin
Senior Medical Affair Director Southern Europe
Giliead Sciences, United Kingdom